Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Prif Awduron: Rachel S Laufer (Awdur), Ranju Baral (Awdur), Andrea G Buchwald (Awdur), James D Campbell (Awdur), Flanon Coulibaly (Awdur), Fatoumata Diallo (Awdur), Moussa Doumbia (Awdur), Amanda J Driscoll (Awdur), Alison P Galvani (Awdur), Adama M Keita (Awdur), Kathleen M Neuzil (Awdur), Samba Sow (Awdur), Clint Pecenka (Awdur), Justin R Ortiz (Awdur), Meagan C Fitzpatrick (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...